# Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)

Study · id `cardio:ct-nct04058990` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04058990](<https://clinicaltrials.gov/study/NCT04058990>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04058990

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

## Technical summary

Registry record NCT04058990. Randomized; single masking; primary purpose treatment. Start 2019-12-12 (actual); primary completion 2021-12-22 (actual). Results posted on 2022-12-23.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 180 participants (enrolled count; ClinicalTrials.gov record NCT04058990, source copy `cardio:ctgov-nct04058990-2026-07-23`, retrieved 2026-10-26)
- Started: 2019-12-12 (actual) (ClinicalTrials.gov record NCT04058990, source copy `cardio:ctgov-nct04058990-2026-07-23`, retrieved 2026-10-26)
- Primary completion: 2021-12-22 (actual) (ClinicalTrials.gov record NCT04058990, source copy `cardio:ctgov-nct04058990-2026-07-23`, retrieved 2026-10-26)
- Completion: 2026-07-07 (actual) (ClinicalTrials.gov record NCT04058990, source copy `cardio:ctgov-nct04058990-2026-07-23`, retrieved 2026-10-26)
- Results first posted: 2022-12-23 (ClinicalTrials.gov record NCT04058990, source copy `cardio:ctgov-nct04058990-2026-07-23`, retrieved 2026-10-26)
- Countries: Japan (ClinicalTrials.gov record NCT04058990, source copy `cardio:ctgov-nct04058990-2026-07-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04058990-2026-07-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)
- Condition: Coronary Artery Disease
- Intervention (Device): Device: Paclitaxel-Coated PTCA Balloon Catheter
- Intervention (Device): SeQuent Please Drug Eluting Balloon Catheter with Paclitaxel
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: e5c7f766bb3e20699f31f87fc5dc01cbcad39e8828f4607de1e73b150ec2bb99
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
